UK & Canada Expand Scope Of Mutual Recognition Of GMP Inspections
Executive Summary
Drug importers can benefit from the UK and Canada’s decision to recognize the outcomes of each other’s manufacturing inspections conducted in foreign jurisdictions.
You may also be interested in...
UK/Canada Deal Lets Drug Agencies Avoid Brexit-Related Trade Disruption
An interim trade deal between the UK and Canada means that the regulators in these countries will carry on accepting each other’s batch testing and GMP certificates.
Evusheld: UK Urged To Use RWD To Give Clinically Vulnerable Early Access To COVID-19 Treatment
A full appraisal by the UK cost watchdog is not the only way to gauge the safety and effectiveness of Evusheld, argues the independent Drug Safety Research Unit in response to the government’s decision not to buy the licensed COVID-19 drug because of insufficient data on protection.
EU Drafts Recommendations On Identifying Suitable RWD Sources For Studies
EU regulators have developed a draft good practice guide explaining how stakeholders can make use of the Metadata Catalog of RWD Sources, which is expected to be released in late 2023, to identify appropriate sources for specific research questions.